Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-26

Clinical Trial Update: To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a nasal dilator strip for reducing nasal resistance and improving sleep-related breathing symptoms in chronic nocturnal nasal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal dilator strip

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sleep Disordered Breathing, Congestion, Nasal | Phase 2 | Status: COMPLETED | Results posted: 2019-07-26